The Role of von Willebrand Factor Antigen in Predicting Survival of Patients with HBV-Related Cirrhosis

Table 3

Multivariate analysis for transplant-free mortality in competing risk model.

Variable	Multivariate analysis
	SHR (95% CI)	P value
MELD	1.09 (1.05, 1.14)	<0.001
CTP stage
Stage A	Reference
Stage B	1.62 (0.88, 3.01)	0.124
Stage C	1.81 (0.88, 3.71)	0.106
vWF-Ag (100 U/mL)	1.10 (1.05, 1.15)	<0.001
CRP (mg/L)	1.01 (1.00, 1.01)	0.071
O blood group (vs. non-O)	0.79 (0.51, 1.23)	0.296

SHR, subdistribution hazard ratio; vWF-Ag, von Willebrand factor antigen; CRP, C-reactive protein.